Cargando…

Driver genes in non-small cell lung cancer: Characteristics, detection methods, and targeted therapies

Lung cancer is one of the most common causes of cancer-related death in the world. The large number of lung cancer cases is non-small cell lung cancer (NSCLC), which approximately accounting for 75% of lung cancer. Over the past years, our comprehensive knowledge about the molecular biology of NSCLC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Qing-Ge, Zhang, Shi-Ming, Ding, Xiao-Xiao, He, Bing, Zhang, Hu-Qin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593676/ https://www.ncbi.nlm.nih.gov/pubmed/28915704 http://dx.doi.org/10.18632/oncotarget.17016

Ejemplares similares

Precision medicine for hepatocellular carcinoma: driver mutations and targeted therapy
por: Ding, Xiao-Xiao, et al.
Publicado: (2017)

Prognostic value of EGFR and KRAS in resected non-small cell lung cancer: a systematic review and meta-analysis
por: Zhang, Shi-Ming, et al.
Publicado: (2018)

Genomic characteristics of driver genes in Chinese patients with non‐small cell lung cancer
por: Si, Xiaoyan, et al.
Publicado: (2020)

Driver gene alterations profiling of Chinese non‐small cell lung cancer and the effects of co‐occurring alterations on immunotherapy
por: Sun, Shengjie, et al.
Publicado: (2021)

Clinical characteristics and patient outcomes of molecular subtypes of small cell lung cancer (SCLC)
por: Ding, Xiao-Long, et al.
Publicado: (2022)

AlloDriver: a method for the identification and analysis of cancer driver targets
por: Song, Kun, et al.
Publicado: (2019)

Recent Progress in Rare Oncogenic Drivers and Targeted Therapy For Non-Small Cell Lung Cancer
por: Guo, Yijia, et al.
Publicado: (2019)

Identifying key regulating miRNAs in hepatocellular carcinomas by an omics’ method
por: He, Bing, et al.
Publicado: (2017)

Case report: Application of targeted NGS for the detection of non-canonical driver variants in MPN
por: Zhang, Jin, et al.
Publicado: (2023)

Former smokers with non‐small‐cell lung cancers: a comprehensive investigation of clinicopathologic characteristics, oncogenic drivers, and prognosis
por: Zheng, Shanbo, et al.
Publicado: (2016)

Exome sequencing identifies somatic mutations in novel driver genes in non-small cell lung cancer
por: Zhang, Manman, et al.
Publicado: (2020)

Co-Occurring Potentially Actionable Oncogenic Drivers in Non-Small Cell Lung Cancer
por: Zhao, Yiming, et al.
Publicado: (2021)

Infrared Small Target Detection Based on Multiscale Kurtosis Map Fusion and Optical Flow Method
por: Xin, Jinglin, et al.
Publicado: (2023)

The Functional Effects of Key Driver KRAS Mutations on Gene Expression in Lung Cancer
por: Zhang, Jisong, et al.
Publicado: (2020)

Multi-Omics Integration-Based Prioritisation of Competing Endogenous RNA Regulation Networks in Small Cell Lung Cancer: Molecular Characteristics and Drug Candidates
por: Wang, Xiao-Jun, et al.
Publicado: (2022)

Comprehensive investigation of oncogenic driver mutations in Chinese non-small cell lung cancer patients
por: Wang, Rui, et al.
Publicado: (2015)

Host-Related Factors as Targetable Drivers of Immunotherapy Response in Non-Small Cell Lung Cancer Patients
por: Baci, Denisa, et al.
Publicado: (2022)

Molecular alterations of driver genes in non-small cell lung cancer: from diagnostics to targeted therapy
por: Grodzka, Anna, et al.
Publicado: (2023)

The O-glycosylating enzyme GALNT2 acts as an oncogenic driver in non-small cell lung cancer
por: Hu, Qing, et al.
Publicado: (2022)

Accurate Driver Detection Exploiting Invariant Characteristics of Smartphone Sensors
por: Ahn, DaeHan, et al.
Publicado: (2019)

Contextualized Small Target Detection Network for Small Target Goat Face Detection
por: Wang, Yaxin, et al.
Publicado: (2023)

Evaluation of Duck Egg Hatching Characteristics with a Lightweight Multi-Target Detection Method
por: Zhou, Jiaxin, et al.
Publicado: (2023)

Prognostic Roles of Glucose to Lymphocyte Ratio and Modified Glasgow Prognosis Score in Patients With Non-small Cell Lung Cancer
por: Yang, Ming, et al.
Publicado: (2022)

Clinicopathological significance of CXCR4 in non-small cell lung cancer
por: Zhou, Xiao-ming, et al.
Publicado: (2015)

YOLO-SASE: An Improved YOLO Algorithm for the Small Targets Detection in Complex Backgrounds
por: Zhou, Xiao, et al.
Publicado: (2022)

Relationship between driver gene mutations and clinical pathological characteristics in older lung adenocarcinoma
por: Liu, Xia, et al.
Publicado: (2023)

Targeting Novel but Less Common Driver Mutations and Chromosomal Translocations in Advanced Non-Small Cell Lung Cancer
por: Daoud, Alia, et al.
Publicado: (2017)

RRM1 expression and the clinicopathological characteristics of patients with non-small cell lung cancer treated with gemcitabine
por: Chen, Ying, et al.
Publicado: (2018)

Non-driver mutations in myeloproliferative neoplasm-associated myelofibrosis
por: Li, Bing, et al.
Publicado: (2017)

Quantification of ethanol in plasma by electrochemical detection with an unmodified screen printed carbon electrode
por: Tian, Gang, et al.
Publicado: (2016)

The clinical value of circulating tumor DNA detection in advanced non-small cell lung cancer
por: Lin, Xiao, et al.
Publicado: (2019)

The Influence of Personality and Demographic Characteristics on Aggressive Driving Behaviors in Eastern Chinese Drivers
por: Liu, Xiao-kun, et al.
Publicado: (2022)

Radiofrequency ablation vs. stereotactic body radiotherapy for stage IA non-small cell lung cancer in nonsurgical patients
por: Li, Ming, et al.
Publicado: (2021)

Chimeric antigen receptor T cells targeting CD147 for non-small cell lung cancer therapy
por: Chen, Xiao-Hong, et al.
Publicado: (2021)

Brain Metastases in Lung Cancers with Emerging Targetable Fusion Drivers
por: Tan, Aaron C., et al.
Publicado: (2020)

Hybrid Cell Structure for Wideband CMUT: Design Method and Characteristic Analysis
por: Wang, Hongliang, et al.
Publicado: (2021)

Multiscale Analysis and Validation of Effective Drug Combinations Targeting Driver KRAS Mutations in Non-Small Cell Lung Cancer
por: Bruggemann, Liana, et al.
Publicado: (2023)

Deep-LC: A Novel Deep Learning Method of Identifying Non-Small Cell Lung Cancer-Related Genes
por: Li, Mo, et al.
Publicado: (2022)

A multiplexed in vivo approach to identify driver genes in small cell lung cancer
por: Lee, Myung Chang, et al.
Publicado: (2023)

Recent progress in targeted therapy for non-small cell lung cancer
por: Xiao, Yanxia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7b1rsj0u7v9ee5tm6dotlsngme